ArriVent BioPharma Inc. C... (AVBP)
NASDAQ: AVBP
· Real-Time Price · USD
19.54
0.92 (4.94%)
At close: Aug 15, 2025, 3:59 PM
19.58
0.20%
After-hours: Aug 15, 2025, 05:41 PM EDT
ArriVent BioPharma Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -31.4M | -64.39M | -20.63M | -20.56M | -21.87M | -17.42M | -21.19M | -14.4M | -21.57M | -12.17M | -10.44M | -11.77M | -7.35M | -7.35M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 3.31M | 2.27M | 952K | 866K | 766K | 625K | 319K | 217K | 193K | 166K | 113K | 113K | 99K | 99K |
Other Working Capital | 2.27M | -6.47M | 4.39M | 2.52M | 2.37M | -1.46M | 5.67M | 972K | 9.07M | -4.5M | -5.58M | -466K | -1.95M | -1.95M |
Other Non-Cash Items | n/a | n/a | n/a | n/a | -347K | -374K | 24K | 2.45M | -3.5M | 546K | 94K | 2.19M | 293K | 293K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.96M | -5.89M | 3.53M | 3.35M | 2.37M | -1.84M | 5.96M | -1.26M | 12.77M | -4.88M | -5.56M | -466K | -1.95M | -1.95M |
Operating Cash Flow | -26.12M | -68.01M | -16.15M | -16.34M | -19.09M | -18.63M | -14.91M | -15.44M | -8.61M | -16.88M | -15.89M | -9.93M | -8.91M | -8.91M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -21.57M | -9.82M | -194.16M | n/a | n/a | n/a | n/a | n/a | -25M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 35.48M | 46.64M | 1.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 13.91M | 36.82M | -192.47M | n/a | n/a | n/a | 25M | n/a | -25M | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 186M | n/a | 44K | 1K | -1.06M | -1.03M | 4K | 26K | 15K | n/a | 30M | 30M |
Financial Cash Flow | 75.11M | 6.76M | 55K | 531K | 363K | 185.63M | -1.06M | -1.03M | -20K | 44.97M | 109.72M | n/a | 30M | 30M |
Net Cash Flow | 62.9M | -24.43M | -208.56M | -15.81M | -18.72M | 167M | 9.03M | -16.48M | -33.63M | 28.09M | 93.83M | -9.93M | 79.46M | n/a |
Free Cash Flow | -26.12M | -68.01M | -16.15M | -16.34M | -19.09M | -18.63M | -14.91M | -15.44M | -8.61M | -16.88M | -15.89M | -9.93M | -8.91M | -8.91M |